CARDIFF ONCOLOGY, INC. Class of Warrant or Right, Outstanding
CARDIFF ONCOLOGY, INC. (CRDF) had Class of Warrant or Right, Outstanding of 432 shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-11
- 2026-06-30: Class of Warrant or Right, Outstanding 432.00 shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 432.00 shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 432.00 shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 1.08M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 432.00 shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 432.00 shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 432.00 shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 1.08M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 2.79M shares 10-Q · filed 2025-07-29 | |
| 2025-03-31 | 2.81M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 2.81M shares 10-K · filed 2026-02-24 | |
| 2024-09-30 | 2.81M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 2.81M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 2.81M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 2.81M shares 10-K · filed 2026-02-24 | |
| 2023-09-30 | 2.81M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 2.81M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 4.30M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 4.36M shares 10-K · filed 2025-02-27 | |
| 2022-09-30 | 4.49M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 4.49M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 4.49M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 4.49M shares 10-K · filed 2024-02-29 | |
| 2021-09-30 | 4.49M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 4.49M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 4.49M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 5.26M shares 10-K · filed 2023-03-02 | |
| 2020-09-30 | 7.37M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 12.33M shares 10-Q · filed 2020-08-11 | |
| 2020-03-31 | 10.52M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 10.59M shares 10-K · filed 2022-02-24 | |
| 2019-09-30 | 4.87M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 4.40M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 3.30M shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 3.65M shares 10-K · filed 2021-02-25 | |
| 2018-09-30 | 22.19M shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | 22.19M shares 10-Q · filed 2018-08-03 | |
| 2018-03-31 | 18.42M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 322.77K shares 10-K · filed 2020-02-27 | 23.24M shares 10-K · filed 2018-02-26 |
| 2017-09-30 | 8.97M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 4.33M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 5.51M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 76.48K shares 10-K · filed 2019-03-06 | 5.51M shares 10-K · filed 2017-03-15 |
| 2016-09-30 | 5.51M shares 10-Q · filed 2016-11-09 | |
| 2016-06-30 | 5.48M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 5.48M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 5.53M shares 10-K · filed 2018-02-26 | |
| 2015-09-30 | 5.53M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 5.70M shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 5.99M shares 10-Q · filed 2015-05-05 | |
| 2014-12-31 | 6.27M shares 10-K · filed 2017-03-15 | |
| 2014-09-30 | 6.30M shares 10-Q · filed 2014-11-06 | |
| 2014-06-30 | 6.30M shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 6.23M shares 10-Q · filed 2014-05-12 | |
| 2013-12-31 | 6.23M shares 10-K · filed 2017-03-15 | |
| 2013-09-30 | 6.31M shares 10-Q · filed 2013-11-14 | |
| 2013-06-30 | 6.80M shares 10-Q · filed 2013-08-14 | |
| 2013-03-31 | 7.01M shares 10-Q · filed 2013-05-14 | |
| 2012-12-31 | 6.99M shares 10-K · filed 2016-03-10 | |
| 2011-12-31 | 3.60M shares 10-K · filed 2015-03-12 | |
| 2010-12-31 | 2.63M shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |